Literature DB >> 9748215

Reversibility of scrapie inactivation is enhanced by copper.

D McKenzie1, J Bartz, J Mirwald, D Olander, R Marsh, J Aiken.   

Abstract

The only known difference between the cellular (PrPC) and scrapie-specific (PrPSc) isoforms of the prion protein is conformational. Because disruption of PrPSc structure decreases scrapie infectivity, restoration of the disease-specific conformation should restore infectivity. In this study, disruption of PrPSc (as monitored by the loss of proteinase K resistance) by guanidine hydrochloride (GdnHCl) resulted in decreased infectivity. Upon dilution of the GdnHCl, protease resistance of PrP was restored and infectivity was regained. The addition of copper facilitated restoration of both infectivity and protease resistance of PrP in a subset of samples that did not renature by the simple dilution of the GdnHCl. These data demonstrate that loss of scrapie infectivity can be a reversible process and that copper can enhance this restoration of proteinase K resistance and infectivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9748215     DOI: 10.1074/jbc.273.40.25545

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Transmission of prions.

Authors:  C Weissmann; M Enari; P-C Klöhn; D Rossi; E Flechsig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

2.  Evaluation of anti-prionic activity of clioquinol in an in vivo model (Mesocricetus auratus).

Authors:  C Pollera; B Lucchini; E Formentin; S Bareggi; G Poli; W Ponti
Journal:  Vet Res Commun       Date:  2005-08       Impact factor: 2.459

3.  Peroxymonosulfate Rapidly Inactivates the Disease-Associated Prion Protein.

Authors:  Alexandra R Chesney; Clarissa J Booth; Christopher B Lietz; Lingjun Li; Joel A Pedersen
Journal:  Environ Sci Technol       Date:  2016-06-20       Impact factor: 9.028

4.  Flotillin-1 mediates PrPc endocytosis in the cultured cells during Cu²⁺ stimulation through molecular interaction.

Authors:  Ke Ren; Chen Gao; Jin Zhang; Ke Wang; Yin Xu; Shao-Bin Wang; Hui Wang; Chan Tian; Qi Shi; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2013-04-27       Impact factor: 5.590

5.  Transport of the pathogenic prion protein through soils.

Authors:  Kurt H Jacobson; Seunghak Lee; Robert A Somerville; Debbie McKenzie; Craig H Benson; Joel A Pedersen
Journal:  J Environ Qual       Date:  2010 Jul-Aug       Impact factor: 2.751

6.  Detection of bovine spongiform encephalopathy, ovine scrapie prion-related protein (PrPSc) and normal PrPc by monoclonal antibodies raised to copper-refolded prion protein.

Authors:  Alana M Thackray; Jean-Yves Madec; Edmond Wong; Robert Morgan-Warren; David R Brown; Thierry Baron; Raymond Bujdoso
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

7.  Quinoline derivatives are therapeutic candidates for transmissible spongiform encephalopathies.

Authors:  Ikuko Murakami-Kubo; Katsumi Doh-Ura; Kensuke Ishikawa; Satoshi Kawatake; Kensuke Sasaki; Jun-Ichi Kira; Shigeru Ohta; Toru Iwaki
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 8.  Prion stability and infectivity in the environment.

Authors:  Richard C Wiggins
Journal:  Neurochem Res       Date:  2008-05-16       Impact factor: 3.996

9.  Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry.

Authors:  R M Whittal; H L Ball; F E Cohen; A L Burlingame; S B Prusiner; M A Baldwin
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

Review 10.  Prion protein conversion in vitro.

Authors:  Surachai Supattapone
Journal:  J Mol Med (Berl)       Date:  2004-03-10       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.